BCI Marketplace
Epilepsy Neurotechnology trials

Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

RecruitingNCT07110454Phase: Not specifiedStarted 2026-06

Summary

The purpose of this research is to address the challenges of correctly monitoring, managing, and diagnosing epilepsy in participants whose seizures are not well captured by standard electroencephalography (EEG) tests and who cannot use or are not able to use more standard monitoring techniques. This research is being done to understand how the Minder System helps physicians make decisions about participant's epilepsy treatment after an actionable event. The Minder System was granted De Novo clas

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
75 Years

Inclusion Criteria: * Participant met all inclusion criteria, was enrolled in the DETECT study, and received the Minder device * Participant completed the DETECT study by receiving an actionable event or by completing the 6-month follow-up visit * Participant continues to have the Minder device imp

Locations

Mayo Clinic - Arizona
Phoenix, Arizona, United States
Stanford
Palo Alto, California, United States
Yale School of Medicine
New Haven, Connecticut, United States
Mayo Clinic - Florida
Jacksonville, Florida, United States
USF Health
Tampa, Florida, United States

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →